AI assistant
Emergent BioSolutions Inc. — Director's Dealing 2010
May 24, 2010
32870_dirs_2010-05-24_618a1c52-638e-4f0c-9dac-7188cb9efa60.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2010-05-20
Reporting Person: Hauer Jerome M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-05-20 | Common Stock | A | 3600 | — | Acquired | 3600 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-05-20 | Director Stock Options (right to buy) | $16.13 | A | 7200 | Acquired | 2020-05-19 | Common Stock (7200) | Direct |
Footnotes
F1: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.
F2: These restricted stock units vest in three equal annual installments beginning on the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
F3: The option will vest in three equal installments on May 21, 2011, May 21, 2012 and May 21, 2013 or, if the Company's Annual Meeting of Stockholders occurs prior to such date for any year, on the day prior to such year's Annual Meeting of Stockholders.